Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single 2 g oral dose of amoxicillin to prevent infection after simple dental implant surgery
2005-005097-78Phase 4Active
- Sponsor
- BTI Biotechnology Institute
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in surgical site infection (SSI) and bacterial disease comparing Amoxicillin 2 g preoperative single dose with Placebo preoperative single dose (2 arms). Primary endpoints: Postoperative infection incidence and Demographic and identification variables. Started Nov 2007; status: active.
02
Drugs
amoxicillin
03
Conditions
surgical site infection (SSI)bacterial disease
Beyond the preview
Go deeper on 2005-005097-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005097-78.